Heron Therapeutics HRTX 深 滬
已收盤 12-12 16:00:00 美东时间
1.37
0.000
0.00%
華盛通- 最 高1.40
- 今 開1.36
- 成交量 190.44万股
- 最 低 1.344
- 昨 收 1.37
- 總市值 2.51亿
- 52周最高 2.68
- 市盈率 靜 --
- 換手率 1.04%
- 52周最低 0.9999
- 委 比 54.00%
- 總股本 1.83亿
- 歷史最高 42.90
- 量 比 0.96
- 振 幅 4.09%
- 歷史最低 0.16
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Heron Therapeutics Includes APONVIE Injectable Emulsion In Guidelines For Postoperative Nausea, Vomiting
Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the inclusion of APONVIE® (aprepitant) injectable emulsion in the newly released Fifth
12-04 21:17
Heron Therapeutics Affirms FY2025 Sales Guidance of $153.000M-$163.000M vs $156.482M Est
Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.000 million-$163.000 million to $153.000 million-$163.000 million vs $156.482 million estimate.
11-04 21:03
Heron Therapeutics Q3 EPS $(0.10) Misses $(0.01) Estimate, Sales $38.213M Miss $39.031M Estimate
Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.01) by 900 percent. This is a 233.33 percent decrease over losses of $(0.03) per share
11-04 21:02
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Heron Therapeutics Appoints Thomas Cusack to Board
Heron Therapeutics ( ($HRTX) ) has issued an update. On October 27, 2025, Heron...
10-30 04:48
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Heron Therapeutics will hold a conference call and webcast on November 4, 2025, at 8:30 a.m. ET to discuss Q3 2025 financial results and recent business highlights. Participants can access the call via a registration link or through Heron's website under the Investor Relations section. An archive will be available post-call. Heron is a biotech company focused on improving patient care through innovative therapeutic developments.
10-21 20:20
Heron Therapeutics Approves Stock Issuance Proposals
Heron Therapeutics ( ($HRTX) ) has issued an announcement. On October 13, 2025,...
10-16 04:29
Heron Therapeutics Signs New Headquarters Lease
Heron Therapeutics ( ($HRTX) ) has shared an update. Heron Therapeutics, Inc. h...
08-29 05:30
HeartCore Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
HeartCore Enterprises Inc., a leading enterprise software and consulting services company, announced that it has regained compliance with the $2.5 million minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. This determination was based on the company’s June 30, 2025, quarterly report, which reported stockholders’ equity of $3,559,017. HeartCore provides SaaS solutions, data analytics services, customer exp...
08-28 12:30
